TheVentureCity participated in Senticell's $7M Seed round alongside Capital Factory, Evoce Capital, Scalpel Ventures, and angel investors.
SEP 1, 2026
Biotechnology and molecular diagnostics company developing a red blood cell (RBC)-based liquid biopsy platform
Biotechnology and molecular diagnostics company developing a red blood cell (RBC)-based liquid biopsy platform. It analyzes RBC-bound DNA, cfDNA, RNA, and protein biomarkers from blood samples to support early disease detection, monitoring, biomarker discovery, and precision medicine. Initial applications include cancer and infectious disease diagnostics, with potential expansion into autoimmune, prenatal, and neurological conditions. The company also describes a therapeutic platform using RBCs,